
Heidi L. Reese
Examiner (ID: 208, Phone: (571)270-5277 , Office: P/1625 )
| Most Active Art Unit | 1625 |
| Art Unit(s) | 1625, 1657, 1622 |
| Total Applications | 1608 |
| Issued Applications | 1298 |
| Pending Applications | 5 |
| Abandoned Applications | 315 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 14230441
[patent_doc_number] => 20190127393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-02
[patent_title] => Lanthanide Toolbox for Organelle Specific Molecular Imaging with Multi-color
[patent_app_type] => utility
[patent_app_number] => 16/176027
[patent_app_country] => US
[patent_app_date] => 2018-10-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10868
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16176027
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/176027 | Lanthanide toolbox for organelle specific molecular imaging with multi-color | Oct 30, 2018 | Issued |
Array
(
[id] => 15912933
[patent_doc_number] => 10653688
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-19
[patent_title] => 6-(6-membered heteroaryl and aryl)isoquinolin-3-yl carboxamides and preparation and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/172553
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51625
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 1955
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16172553
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/172553 | 6-(6-membered heteroaryl and aryl)isoquinolin-3-yl carboxamides and preparation and use thereof | Oct 25, 2018 | Issued |
Array
(
[id] => 14993557
[patent_doc_number] => 20190315736
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate
[patent_app_type] => utility
[patent_app_number] => 16/172411
[patent_app_country] => US
[patent_app_date] => 2018-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11520
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16172411
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/172411 | Crystalline Form of (R)-7-Chloro-N-(Quinuclidin-3-YL)benzo[B]thiophene-2-Carboxamide Hydrochloride Monohydrate | Oct 25, 2018 | Abandoned |
Array
(
[id] => 16817019
[patent_doc_number] => 11001826
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-11
[patent_title] => Orally administered composition to lower serum methionine levels and method of use
[patent_app_type] => utility
[patent_app_number] => 16/165879
[patent_app_country] => US
[patent_app_date] => 2018-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 2512
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16165879
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/165879 | Orally administered composition to lower serum methionine levels and method of use | Oct 18, 2018 | Issued |
Array
(
[id] => 15800699
[patent_doc_number] => 20200123492
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-23
[patent_title] => BIOLOGICAL DISINFECTION OR STERILIZATION INDICATOR
[patent_app_type] => utility
[patent_app_number] => 16/164418
[patent_app_country] => US
[patent_app_date] => 2018-10-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10163
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16164418
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/164418 | Biological disinfection or sterilization indicator | Oct 17, 2018 | Issued |
Array
(
[id] => 17784622
[patent_doc_number] => 11407734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-09
[patent_title] => Preparation method for tyrosine kinase inhibitor and intermediate thereof
[patent_app_type] => utility
[patent_app_number] => 16/756782
[patent_app_country] => US
[patent_app_date] => 2018-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5641
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 143
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756782
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756782 | Preparation method for tyrosine kinase inhibitor and intermediate thereof | Oct 16, 2018 | Issued |
Array
(
[id] => 17162936
[patent_doc_number] => 11149023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-19
[patent_title] => Substituted triazole derivatives and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/758345
[patent_app_country] => US
[patent_app_date] => 2018-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30342
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16758345
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/758345 | Substituted triazole derivatives and uses thereof | Oct 16, 2018 | Issued |
Array
(
[id] => 16900674
[patent_doc_number] => 20210179590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-17
[patent_title] => SUBSTITUTED TRIAZOLE DERIVATIVES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/758744
[patent_app_country] => US
[patent_app_date] => 2018-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33688
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 255
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16758744
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/758744 | Substituted triazole derivatives and uses thereof | Oct 16, 2018 | Issued |
Array
(
[id] => 16824182
[patent_doc_number] => 20210139475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => Broad Spectrum Antiviral Compositions and Methods
[patent_app_type] => utility
[patent_app_number] => 16/756734
[patent_app_country] => US
[patent_app_date] => 2018-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31440
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756734
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756734 | Broad spectrum antiviral compositions and methods | Oct 16, 2018 | Issued |
Array
(
[id] => 16915719
[patent_doc_number] => 20210188811
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4
[patent_app_type] => utility
[patent_app_number] => 16/756430
[patent_app_country] => US
[patent_app_date] => 2018-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 194
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756430
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756430 | Antagonists of the muscarinic acetylcholine receptor M4 | Oct 16, 2018 | Issued |
Array
(
[id] => 16359294
[patent_doc_number] => 20200316045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-08
[patent_title] => SUBSTITUTED TRIAZOLE DERIVATIVES AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/756623
[patent_app_country] => US
[patent_app_date] => 2018-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 83502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 1756
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16756623
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/756623 | Substituted triazole derivatives and uses thereof | Oct 16, 2018 | Issued |
Array
(
[id] => 14360097
[patent_doc_number] => 10301336
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Phosphonate compounds for treatment of complement mediated disorders
[patent_app_type] => utility
[patent_app_number] => 16/162162
[patent_app_country] => US
[patent_app_date] => 2018-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25981
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 806
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16162162
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/162162 | Phosphonate compounds for treatment of complement mediated disorders | Oct 15, 2018 | Issued |
Array
(
[id] => 14185251
[patent_doc_number] => 20190112330
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-18
[patent_title] => BILE SALT HYDROLASE PROBE AND METHOD OF MAKING AND USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/159429
[patent_app_country] => US
[patent_app_date] => 2018-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16159429
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/159429 | Bile salt hydrolase probe and method of making and using the same | Oct 11, 2018 | Issued |
Array
(
[id] => 13867351
[patent_doc_number] => 20190030016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => ANALOGS OF PRIDOPIDINE, THEIR PREPARATION AND USE
[patent_app_type] => utility
[patent_app_number] => 16/150977
[patent_app_country] => US
[patent_app_date] => 2018-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21209
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -76
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16150977
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/150977 | Analogs of pridopidine, their preparation and use | Oct 2, 2018 | Issued |
Array
(
[id] => 15355371
[patent_doc_number] => 10526285
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Therapeutic compounds and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/150070
[patent_app_country] => US
[patent_app_date] => 2018-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 73959
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16150070
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/150070 | Therapeutic compounds and methods of use thereof | Oct 1, 2018 | Issued |
Array
(
[id] => 13793997
[patent_doc_number] => 20190010537
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => REAL-TIME MONITORING
[patent_app_type] => utility
[patent_app_number] => 16/137832
[patent_app_country] => US
[patent_app_date] => 2018-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13893
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16137832
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/137832 | Real-time monitoring | Sep 20, 2018 | Issued |
Array
(
[id] => 17490401
[patent_doc_number] => 11279690
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-22
[patent_title] => Inhibitors of glutaminyl cyclase
[patent_app_type] => utility
[patent_app_number] => 16/650631
[patent_app_country] => US
[patent_app_date] => 2018-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19625
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16650631
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/650631 | Inhibitors of glutaminyl cyclase | Sep 19, 2018 | Issued |
Array
(
[id] => 14072971
[patent_doc_number] => 20190085373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => CHEMICAL TOOLS FOR IMAGING PHOSPHOLIPASE D ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/131798
[patent_app_country] => US
[patent_app_date] => 2018-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16131798
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/131798 | Chemical tools for imaging phospholipase D activity | Sep 13, 2018 | Issued |
Array
(
[id] => 13928883
[patent_doc_number] => 20190047957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-14
[patent_title] => BIPHENYL COMPOUNDS USEFUL AS MUSCARINIC RECEPTOR ANTAGONISTS
[patent_app_type] => utility
[patent_app_number] => 16/130076
[patent_app_country] => US
[patent_app_date] => 2018-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22732
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16130076
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/130076 | Biphenyl compounds useful as muscarinic receptor antagonists | Sep 12, 2018 | Issued |
Array
(
[id] => 13793165
[patent_doc_number] => 20190010121
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOBLOGIN
[patent_app_type] => utility
[patent_app_number] => 16/127776
[patent_app_country] => US
[patent_app_date] => 2018-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17399
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16127776
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/127776 | COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOBLOGIN | Sep 10, 2018 | Abandoned |